Template talk:Serotonin receptor modulators

This is the talk page for discussing improvements to the Serotonin receptor modulators template.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

This template is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology

Chemicals

This template is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this template or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals

Medicine

This template is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine

Molecular Biology: MCB

	This template is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology
	This template is supported by the Molecular and Cell Biology task force.

Anabolic-androgenic steroids

Should Anabolic-androgenic steroids be moved under Cofactors?.--David Hedlund (talk) 05:34, 2 December 2013 (UTC)[reply]

Linking as navpage rather than navbox

The navbox Template:Serotonergics can be linked to an article as 1 wikilink, rather than over 875, by displaying it in a navpages-box, as shown below. Some users might have difficulty editing an article, when waiting for the Serotonergics navbox to be reformatted, during each edit-preview.

Medicine portal Related navpages: Serotonergics (over 870 topics)

The following markup connects Serotonergics as a navpage, and defers the 875+ wikilinks, which otherwise cause database links to be updated for those 875+ other articles:

{| class=wikitable width="99%"
| bgcolor="#F1F1FC" | {{portal|Medicine}}
: '''Related navpages''':
:* [[Template:Serotonergics|Serotonergics]] (over 870 topics)
|}

Users editing from smaller devices might have difficulty editing an article, when awaiting the Serotonergics navbox to be reformatted, during each edit-preview, while waiting for the edit-text window to appear, following the extensive typesetting of the 875 wikilinks in the Serotonergics table-box. By using the above navpages-box, then editing an article becomes much, much faster, as the edit-text window quickly appears on the edit page. -Wikid77 (talk) 17:24, 13 April 2010 (UTC)[reply]

image navigation of molecules

The names of a lot of these molecules are not very revealing when it comes to their structural relationship to their effect. I'd really like to make a version of thi template that would have image links which are pictures of the molecule which will show the name on mouse hover and link to that article. I'll have to look into this more but I';m sure theres a simple way to do this RotogenRay (talk) 01:37, 5 July 2014 (UTC)Rotogenray on july 4[reply]

Semi-protected edit request on 13 January 2016

This edit request to Template:Serotonergics has been answered. Set the |answered= or |ans= parameter to no to reactivate your request.

Need to change medifoxamine to a 5-HT2A and 5-HT2C receptor antagonist instead of agonist. 2605:E000:8789:D800:D4BD:CD0A:A5A7:D7C (talk) 19:40, 13 January 2016 (UTC)[reply]

Not done: it's not clear what changes you want to be made. Please mention the specific changes in a "change X to Y" format. With the complexity of this topic and the template, I'm not sure what exactly I should be changing here --allthefoxes ^(Talk) 16:44, 20 January 2016 (UTC)[reply]

It looks like this change was done yesterday. Seppi333 (Insert 2¢) 16:47, 20 January 2016 (UTC)[reply]

psilocybin

Should we keep psilocybin in there since it's a prodrug? I think we should remove it since psilocin, it's active sibling, is already there. Cganuelas (talk) 06:11, 30 November 2020 (UTC)[reply]

Broken Link

This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request.

Please fix the MMDA (drug) link at the end of the 5-HT2B agonists list. That MMDA entry (there's another one as well but that link is correct) has only one [ character in front, it should have two. 2607:FEA8:E31F:FBC1:E0F4:E500:59C2:F9A5 (talk) 23:47, 12 February 2021 (UTC)[reply]

Done - see Special:Diff/1006463329. Thank you! DanCherek (talk) 01:05, 13 February 2021 (UTC)[reply]

Semi-protected edit request on 12 November 2021

This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request.

ad Chlorprothixene to 5-HT2A antagonist, it has very significant binding affinity in contrary to other typical neuroleptic Yellow whisper (talk) 18:49, 12 November 2021 (UTC)[reply]

Not done: it's not clear what changes you want to be made. Please mention the specific changes in a "change X to Y" format and provide a reliable source if appropriate. ScottishFinnishRadish (talk) 18:54, 12 November 2021 (UTC)[reply]

Done --ἀνυπόδητος (talk) 08:40, 13 November 2021 (UTC)[reply]